Life Sciences
Paul Scherrer Institute and Apollo Health Ventures Launch Focal Biosciences
TechTransfer
PSI
Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.
Making tumour diagnosis kinder to kidneys
Research
PSI
Researchers at the Paul Scherrer Institute PSI, in collaboration with ETH Zurich, have optimised a method for tumour diagnosis using radionuclides. Potential side-effects can now be significantly reduced through a molecular trick. The researchers report their results in the current issue of the scientific journal Bioorganic & Medicinal Chemistry.
Protein scissors for more effective cancer treatment
Research
ETH Zurich
ETH Zurich biologist Daniel Richter has developed a method that enables proteins to be linked to a drug molecule or biomarker with a high level of stability. He plans to use this method in the future to identify tumour cells and open the door to more effective cancer drugs.
A window into the fruit fly's nervous system
Research
EPFL
Scientists at EPFL have developed an implantation technique that allows unprecedented optical access to the “spinal cord” of the fruit fly, Drosophila melanogaster. This work can potentially lead to breakthroughs in the fields of neuroscience, artificial intelligence, and bio-inspired robotics.
Stressed mitochondria help cells survive respiratory infections
Research
EPFL
Mildly stressing mitochondria with an antibiotic can increase tolerance against respiratory infections, shows a study by scientists at EPFL.
Challenging the standard paradigm of schizophrenia research
Research
EPFL
Analyzing EEG measurements of almost two hundred schizophrenia patients and healthy controls, researchers at EPFL now challenge the standard paradigm underlying research in the field.
Page 8 of 16